BOT 3.13% 33.0¢ botanix pharmaceuticals ltd

My point is that what are in fact conclusions are presented as...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,125 Posts.
    lightbulb Created with Sketch. 173
    My point is that what are in fact conclusions are presented as aims right after "Botanix commissioned a leading US skin testing laboratory ...", and although I doubt that the lab was asked/required to come to the desired conclusion, the juxtaposition does not look very elegant to me, and nor do "fail to live up to" and "fail to deliver". I also think Botanix needs to very confident of what constitutes a therapeutically effective amount of CBD and should have worked harder to produce a suitably bland statement which nevertheless gets the points across.

    While some in Botanix may believe that the share price is sitting around 10 cents because insufficient noise has been made about its achievements there are others, including myself, who point to other reasons the company is in a state of being "sold short" - one being share fire-sales and associated manoeuvres.

    So I will be blunt: my take is that Marketing (in its widest sense) needs to be kept under closer control and the crown jewels need to be more carefully displayed and more closely guarded.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $707.4M
Open High Low Value Volume
32.0¢ 33.0¢ 31.5¢ $632.4K 1.968M

Buyers (Bids)

No. Vol. Price($)
9 275326 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 552467 15
View Market Depth
Last trade - 14.39pm 25/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.